Introducing REXULTI® (brexpiprazole): a new PBS-listed antipsychotic for schizophrenia
Por um escritor misterioso
Descrição
October 1st sees the PBS listing of REXULTI, a novel antipsychotic indicated for the treatment of adults with schizophrenia.
Rexulti 1 Mg, Antipsychotic - 28 Tablets
Dichlorophenyl piperazines, including a recently-approved atypical antipsychotic, are potent inhibitors of DHCR7, the last enzyme in cholesterol biosynthesis. - Abstract - Europe PMC
Rexulti.PDF
PDF] Brexpiprazole (Rexulti): A New Monotherapy for Schizophrenia and Adjunctive Therapy for Major Depressive Disorder.
Full article: In vitro evaluations for pharmacokinetic drug-drug interactions of a novel serotonin-dopamine activity modulator, brexpiprazole
Patient Group Input Submissions: Brexpiprazole (Rexulti) - NCBI Bookshelf
Michael Okun on X: Brexpiprazole (Rexulti) approved by FDA for #Alzheimers agitation. Will it find its way to #Parkinsons? Depends on if it makes motor symptoms significantly worse. It works on D2
Full article: Pharmacokinetics and metabolism of brexpiprazole, a novel serotonin-dopamine activity modulator and its main metabolite in rat, monkey and human
Mechanism of action of brexpiprazole: comparison with aripiprazole, CNS Spectrums
The Best and Worst Antipsychotics for Mania - Part 3, 2021-11-01
1mg REXULTI TABLET, Schizophrenia, Intas Pharmaceuticals
Rexulti Approved by FDA for Major Depressive Disorder and Schizophrenia
de
por adulto (o preço varia de acordo com o tamanho do grupo)
